In March, we had the unique opportunity to travel to Oslo, Norway to visit the Thermo Fisher Scientific research facilities at Norwegian Radium Hospital and meet Norway's first pediatric CAR-T patient, 15-year old Simen Aarskog.
On February 23, we had the honor to attend the Liberty Ball in Philadelphia and be presented with the 4th Annual Kayla Nakonechni Knight Award, which recognizes a leader and an advocate in the fight against pediatric cancer.
On Tuesday, February 12, Tom Whitehead traveled to Greensboro, NC to speak and share his story at Corning Life Sciences global sales meeting, followed by a Q&A with Chris Mach, Corning's Director of Cell and Gene Therapy Strategy.
During the week of January 22-24, 2019 we had the honor to attend the co-located Phacilitate Leaders World and World Stem Cell Summit 2019 conferences in Miami, Florida and host a yacht party fundraiser in partnership with Phacilitate — which raised a total $17,350!
It's our anniversary! It has been four years to the date since we first launched the Emily Whitehead Foundation. Thank you to all who have supported us thus far in our journey.
On January 3, 2019, we began the new year by joining members of our local community at the 4th Annual Take Down Cancer Event benefitting the Emily Whitehead Foundation. Thanks to the combined fundraising efforts of the Philipsburg-Osceola and Clearfield school districts and high school wrestling clubs, this year's event raised a total $11,205 to help further childhood cancer research!
On November 2, 2018 Nicole Gularte became the very first patient in a brand new CART-22 clinical trial at Penn Medicine — following a relapse of her cancer after participating in the CTL019 CAR-T cell therapy trial in October 2016.
Over the weekend of November 17-18, we traveled to Philadelphia to support our team of runners participating in the 2018 Philadelphia Marathon. In four years as an official charity partner, Team EWF has now raised over $143,000 through Philadelphia Marathon fundraising efforts!
Emily Whitehead Foundation and Phacilitate to Hold Yacht Party Fundraiser at Phacilitate Leaders World in Miami
In an effort to bring more awareness to pediatric cancer immunotherapy research, the Emily Whitehead Foundationand London-based Phacilitate are joining together to hold a one of a kind fundraising event in Miami, Florida on January 24, 2019.
On October 16, 2018, we had the honor of sharing our story and inspiring attendees at the Sysmex Symposium in Philadelphia.
On Friday, September 7 we traveled to Los Angeles to attend the sixth annual Stand Up To Cancer telecast. In a special moment during the show, Emily and fellow cancer survivor Nick were given the opportunity to thank the doctors and researchers who treated them.
On August 27, the European Commission announced that Novartis CAR-T cell therapy Kymriah has been approved to treat pediatric and adult patients with relapsed/refractory acute lymphoblastic leukemia (ALL) and relapsed/refractory diffuse large B-cell lymphoma (DLBCL) in Europe.